Search

23 Oct 2020: Share:. A new spin-out company from the University of Cambridge and Addenbrooke’s Hospital, X01 Ltd, has raised $11 million in funding to develop a new anticoagulant drug which has ... The investment, which comes from the $200 million Life Sciences

23 Oct 2020: Stuart Travers. Approximately 2,000 new cases of AML are diagnosed each year in the UK. ... The search for new drugs and methods of determining efficacy is of great importance to clinicians and the general public.

23 Oct 2020: ERBA Diagnostics Mannheim GmbH announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products. Read more.

23 Oct 2020: PneumaCare, founded in 2008, has developed a non-invasive technology for monitoring lung function, known as PneumaScan. Read more here.

23 Oct 2020: Researchers from the UK and Spain have identified an eco-friendly solid that could replace the inefficient and polluting gases used in most refrigerators and air conditioners. Cambridge Enterprise is working to bring it to market.

23 Oct 2020: During this time, 400 new knowledge and technology transfer transactions were completed, bringing the portfolio to over 700 active equity, consultancy and licence agreements under management.

23 Oct 2020: One of the purposes of the seminar –which focused on research in biological sciences and energy—was to explore ways in which these links can be strengthened, and new links developed.

23 Oct 2020: Nanjing’s Jiangbei New Area, a pilot urban development based on high levels of technological innovation. ... As well as supporting health and wellbeing in new cities, the new Centre will help deliver efficient energy use through its academic and

23 Oct 2020: University of Cambridge spin-out X01 Limited, a company founded to develop the anti-thrombin antibody ichorcumab, has been acquired by Janssen. Read more.

23 Oct 2020: This course is designed to help University staff understand potential problems associated with expert witness work and how to avoid them. Read more here.